REVB   $0.92  8.24% Market Closed After Close 0.92 0.0

Revelation Biosciences Inc
Total Cash 12.07M
totalCashPerShare 7.346
EBITDA -9.50M
Total Debt 0.00
quickRatio 1.085
currentRatio 1.096
Total Revenue
debtToEquity
Revenue/Share
ROA -0.42074
ROE -2.53321
grossProfits
freeCashflow 834.40K
operatingCashflow -9.04M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -10.67M
forwardPE -0.15341726
floatShares 1.64M
sharesOutstanding 3.76M
sharesShort 56.57K
sharesShortPriorMonth 120.39K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.01%
Short Ratio help_outline 0.21%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 0.694
Price To Book help_outline 1.23
earningsQuarterlyGrowth
netIncomeToCommon -15.90M
trailingEps -33.18%
forwardEps -5.56%
enterpriseToEbitda 1.12
lastDividendValue
lastDividendDate
currentQuarterEstimate -2.84 3Q 2024
institutionsCount 8
lastUpdated Oct. 17, 2024, 4:05 a.m.